IN8bio

INAB · NASDAQ

$1.14+$0.05 (+4.59%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $1.09

Latest news

Press releaseAug 6, 4:01 PM ETGlobe Newswire
IN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights
NewsJul 23, 5:06 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseJul 9, 8:00 AM ETGlobe Newswire
IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma
Press releaseMay 7, 4:30 PM ETGlobe Newswire
IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
Press releaseMay 6, 8:00 AM ETGlobe Newswire
IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences
Press releaseMar 12, 4:01 PM ETGlobe Newswire
IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026
Press releaseFeb 24, 8:00 AM ETGlobe Newswire
IN8bio to Present at TD Cowen 46th Annual Health Care Conference
Press releaseFeb 9, 8:00 AM ETGlobe Newswire
IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer
NewsNov 6, 4:06 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseNov 6, 4:00 PM ETGlobe Newswire
IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Press releaseAug 7, 4:00 PM ETGlobe Newswire
IN8bio Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Press releaseJun 9, 7:00 AM ETGlobe Newswire
IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial
NewsJun 9, 6:21 AM ETRishabh Mishra
US Stocks Likely To Open On A Mixed Note After S&P 500 Scales 6,000-Mark: 'Whole Globe Is In A Bull Market'
Press releaseJun 2, 7:30 AM ETGlobe Newswire
IN8bio Presents Positive Phase 1 Data of INB-200 in Newly Diagnosed GBM Demonstrating Prolonged Progression-Free Survival
NewsMay 15, 8:09 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press releaseMay 14, 8:00 AM ETGlobe Newswire
IN8bio Presents Preclinical Data Highlighting Potential of INB-619 T Cell Engager (TCE) for Autoimmune Disease at ASGCT 2025
Press releaseMar 13, 4:05 PM ETGlobe Newswire
IN8bio Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
Press releaseMar 3, 9:28 AM ETGlobe Newswire
IN8bio Announces Advanced Gamma-Delta (γδ) T cell Engager (TCE) Platform for Oncology and Autoimmune Diseases
Press releaseFeb 26, 8:00 AM ETGlobe Newswire
IN8bio to Present at the TD Cowen 45th Annual Health Care Conference
Press releaseFeb 24, 8:00 AM ETGlobe Newswire
IN8bio to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
NewsFeb 12, 4:05 PM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsFeb 12, 7:05 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsFeb 11, 4:06 PM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Press releaseFeb 11, 8:00 AM ETGlobe Newswire
IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients
Press releaseDec 2, 7:00 AM ETGlobe Newswire
IN8bio to Present at Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference
NewsOct 23, 4:31 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsOct 22, 10:03 AM ETAvi Kapoor
Dow Falls Over 150 Points; General Motors Tops Q3 Views
NewsOct 22, 8:07 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsOct 22, 8:07 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsOct 22, 7:06 AM ETAvi Kapoor
Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
NewsOct 2, 11:04 AM ET
Watching IN8bio; Zacks Small-Cap Research Gives Stock $1.50 Price Valuation
Press releaseAug 29, 6:05 AM ETGlobe Newswire
IN8bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

IN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights

12 Health Care Stocks Moving In Thursday's After-Market Session

IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma

IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights

IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences

IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026

IN8bio to Present at TD Cowen 46th Annual Health Care Conference

IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer

12 Health Care Stocks Moving In Thursday's After-Market Session

IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights

IN8bio Reports Second Quarter 2025 Financial Results and Recent Business Highlights

IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial

US Stocks Likely To Open On A Mixed Note After S&P 500 Scales 6,000-Mark: 'Whole Globe Is In A Bull Market'

IN8bio Presents Positive Phase 1 Data of INB-200 in Newly Diagnosed GBM Demonstrating Prolonged Progression-Free Survival

12 Health Care Stocks Moving In Thursday's Pre-Market Session

IN8bio Presents Preclinical Data Highlighting Potential of INB-619 T Cell Engager (TCE) for Autoimmune Disease at ASGCT 2025

IN8bio Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights

IN8bio Announces Advanced Gamma-Delta (γδ) T cell Engager (TCE) Platform for Oncology and Autoimmune Diseases

IN8bio to Present at the TD Cowen 45th Annual Health Care Conference

IN8bio to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients

IN8bio to Present at Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference

12 Health Care Stocks Moving In Wednesday's After-Market Session

Dow Falls Over 150 Points; General Motors Tops Q3 Views

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Watching IN8bio; Zacks Small-Cap Research Gives Stock $1.50 Price Valuation

IN8bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference